Continuous Supraglottic Aspiration in Intubated and Mechanically Ventilated Patients: the SUPRAtube Device

Evaluation of the Effectiveness and Safety of an Own-invention System for Continuous Supraglottic Aspiration in Intubated and Mechanically Ventilated Patients: the SUPRAtube Device

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03573635

Acronym

Supratube

Enrollment

Registered

2018-06-29

Start date

2016-01-10

Completion date

2017-12-20

Last updated

2018-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aspiration Pneumonias

Brief summary

Purpose of the trial: Evaluate the efficacy and safety of the device of self-invention of continuous oropharyngeal aspiration denominated SUPRAtube in patients with orotracheal intubation and mechanical ventilation.

Interventions

DEVICESupratube

Aspiration of orotracheal secretions with supratube device

OTHERReference

Usual aspiration with any other device

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

OTHER

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

• Endotracheal intubation and invasive mechanical ventilation,

Exclusion criteria

* Immediate postoperative oral cavity. * Traumatic oral cavity injury. * Platelet count less than 50000.

Design outcomes

Primary

Measure	Time frame	Description
aspirated secretions	24 hours after intubation	volume of aspirated secretions

Secondary

Measure	Time frame	Description
Adverse events	24 hours after intubation	Adverse events related to supratube device use

Countries

Colombia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026